Vexxa Lifesciences Private Limited, a active private limited company, was established on 03 November 2011 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230MH2011PTC284061. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.70 Cr.
It upholds a compliant status. Its leadership includes Yogesh Vasudev Khadke (Director), Kanan Chetan Sheth (Director), Jash Pranav Dalal (Director). Past directors included Yogesh Vasudev Khadke, Shharad Singhania, Pramod Nandkishore Goyal. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 401, 4Th Floor, Mehta Mahal, 15Th Mathew Road, Opera House, Charni Ro, Ad (East),, Mumbai, Maharashtra, 400004.
U24230MH2011PTC284061
284061
03 November 2011
₹5.00 Cr
₹2.70 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Vexxa Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yogesh Vasudev Khadke | Director | 12 Apr 2016 | Current |
| Kanan Chetan Sheth | Director | 26 May 2015 | Current |
| Jash Pranav Dalal | Director | 16 Jun 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Jul 2017 | Past |
| Pramod Abcsdd | Director | 13 Apr 2016 | Past |
| Pramod Abcsdd | Director | 21 Dec 2015 | Past |
| Pramod Abcsdd | Director | 27 May 2015 | Past |
| Pramod Abcsdd | Director | 27 May 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vexxa Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 17.36% increase. The company also saw a substantial fall in profitability, with a 42.72% decrease in profit. The company's net worth moved up by a moderate rise of 7.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Vexxa Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Vexxa Lifesciences has a workforce of 0 employees as of Dec 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vexxa Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vexxa Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vexxa Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Vexxa Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Jash Pranav Dalal was appointed as a Director was appointed as a Director on 16 Jun 2017 & has been associated with this company since 8 years 5 months . was recorded as a recent event.
The activity Yogesh Vasudev Khadke was appointed as a Director was appointed as a Director on 12 Apr 2016 & has been associated with this company since 9 years 7 months . was completed.
The activity Kanan Chetan Sheth was appointed as a Director was appointed as a Director on 26 May 2015 & has been associated with this company since 10 years 6 months . was completed.
Vexxa Lifesciences Private Limited was registered on 03 Nov 2011 with Roc Mumbai & aged 14 years 22 days as per MCA records. was recorded as a recent event.
The CIN of Vexxa Lifesciences Private Limited is U24230MH2011PTC284061.
Vexxa Lifesciences Private Limited is headquartered at 401, 4Th Floor, Mehta Mahal, 15Th Mathew Road, Opera House, Charni Ro, Ad (East),, Mumbai, Maharashtra, 400004.
Vexxa Lifesciences Private Limited was incorporated on 03 November 2011.
The current directors of Vexxa Lifesciences Private Limited are
The primary industry of Vexxa Lifesciences Private Limited is Trade.
Vexxa Lifesciences Private Limited is unlisted.
The authorized capital of Vexxa Lifesciences Private Limited is ₹5.00 Cr, and the paid-up capital is ₹2.70 Cr.
The compliance status of Vexxa Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX